NCT07151339Recruiting
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie
Source: ClinicalTrials.gov · Last updated 3 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 20 Aug 2025
- Start date
- 1 Nov 2024
- Primary completion date
- Nov 2029
- Lead sponsor
- University Hospital Schleswig-Holstein
- NCT number
- NCT07151339
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Nov 2024 to the primary completion date, Nov 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- unable for informed consent
Who the study is looking for
- older than 18 yrs
- diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Schleswig-Holstein Coordinator of this site? Confirm its status | Kiel | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.